The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia (Q39643259)
Jump to navigation
Jump to search
scientific article published on October 15, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia |
scientific article published on October 15, 2010 |
Statements
1 reference
The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia (English)
1 reference
Philip Saunders
1 reference
Adam Cisterne
1 reference
Jocelyn Weiss
1 reference
Kenneth F. Bradstock
15 October 2010
1 reference
1 reference
96
1 reference
1
1 reference
69-77
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference